美股市场个股详情
BAX 百特国际
- 33.710
- +0.570+1.72%
收盘价 11/29 13:00 (美东)
- 33.710
- 0.0000.00%
盘后 15:30 (美东)
172.12亿总市值153.23市盈率TTM
33.810最高价33.110最低价292.83万股成交量33.110今开33.140昨收9859.43万成交额0.58%换手率6.42市盈率(静)5.11亿总股本43.07052周最高2.19市净率171.15亿流通值31.43952周最低1.16股息TTM5.08亿流通股86.323历史最高3.44%股息率TTM2.11%振幅11.907历史最低33.669平均价1股每手
关于百特国际公司
百特为护理人员提供各种医疗器械和设备。百特通过其传统业务销售用于护理环境的注射疗法，包括静脉输液泵、给药套件和溶液；营养产品；以及手术密封剂和止血剂。通过在2021年底收购Hillrom，百特扩展了以医院为重点的产品组合，增加了包括医院病床、手术室设备和患者监测工具等在内的基本设备。该公司已经签署了一项协议，将在2025年初出售其肾脏护理工具。
公司介绍
公司代码BAX
公司名称百特国际
上市日期1961/05/15
成立日期1931
CEOMr. Jose E. Almeida
所属市场纽交所
员工数量60000
年结日12-31
公司地址One Baxter Parkway
城市Deerfield
省份伊利诺伊州
国家美国
邮编60015-4625
电话1-224-948-2000
董事高管
- 姓名
- 职务
- 年薪
- Jose E. Almeida
- Chairman of the Board, Chief Executive Officer and President
- 1378.67万
- Jeanne K. Mason
- Executive Vice President and Chief Human Resources Officer
- --
- James W. Borzi
- Executive Vice President and Chief Supply Chain Officer
- --
- Joel T. Grade
- Executive Vice President, Chief Financial Officer and Interim Chief Accounting Officer
- 487.62万
- Heather L. Knight
- Executive Vice President and Group President, Medical Products and Therapies
- 486.02万
- Reazur Rasul
- Executive Vice President and Group President, Healthcare Systems and Technologies
- --
- Alok Sonig
- Executive Vice President and Group President, Pharmaceuticals
- 386.60万
- Christopher A. Toth
- Executive Vice President and Group President, Kidney Care
- 964.03万
- David S. Rosenbloom
- Executive Vice President and General Counsel
- --
- Jeffrey A. Craig
- Director
- --
- Cathy R. Smith
- Independent Director
- 36.73万
- William A. Ampofo, II
- Independent Director
- 22.64万
- Patricia B. Morrison
- Independent Director
- 36.50万
- Stephen H. Rusckowski
- Independent Director
- 19.78万
- D. Brent Shafer
- Lead Independent Director
- 38.23万
- Peter M. Wilver
- Independent Director
- 34.96万
- Dr. David S. Wilkes
- Independent Director
- 35.70万
- Amy A. Wendell
- Independent Director
- 35.30万
- Nancy M. Schlichting
- Independent Director
- 36.30万
- Dr. Stephen Newman Oesterle, M.D.
- Independent Director
- 37.40万
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据